← Evidence map

ArticleJournal of comparative effectiveness research2025

Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression.

Kristin Clemens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40485482